Skip to content

Randomised Controlled Trial of Exposure and Cognitive Restructuring for Reduction in Posttraumatic Stress Disorder (PTSD) Symptoms

Randomised Controlled Trial of Exposure and Cognitive Restructuring for Reduction in Posttraumatic Stress Disorder (PTSD) Symptoms After Exposure to Any Traumatic Event

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ANZCTR
Registry ID
ACTRN12610000017022
Enrollment
118
Registered
2010-01-07
Start date
2005-03-01
Completion date
Unknown
Last updated
2020-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This study will randomly allocate patients with PTSD to either (a) imaginal exposure, (b) in vivo exposure, (c) combined imaginal and in vivo exposure, or (d) combined imaginal, in vivo exposure, and cognitive restructuring.

Interventions

There are 4 arms to this trial. Arm 1: Imaginal Exposure only. Arm 2: In Vivo Exposure only. Arm 3: Imaginal Exposure and In Vivo Exposure combined. Arm 4: Imaginal Expsoure, In Vivo Exposure and Cognitive Restructuring combined. Therapy is administered in once-weekly 90-minute sessions of one-on-one therapy with a clinical psychologist over 8 weeks. Imaginal exposure includes imaginal reliving of trauma memories. In vivo exposure includes gradual exposure to feared situations. Cognitive res

There are 4 arms to this trial. Arm 1: Imaginal Exposure only. Arm 2: In Vivo Exposure only. Arm 3: Imaginal Exposure and In Vivo Exposure combined. Arm 4: Imaginal Expsoure, In Vivo Exposure and Cognitive Restructuring combined. Therapy is administered in once-weekly 90-minute sessions of one-on-one therapy with a clinical psychologist over 8 weeks. Imaginal exposure includes imaginal reliving of trauma memories. In vivo exposure includes gradual exposure to feared situations. Cognitive restructuring includes training reappraisal of the trauma experience. The duration of the study for any participant will conclude after the 6-month follow-up assessment, resulting in participation duration of 8 months.

Sponsors

University of New South Wales
Lead SponsorUniversity

Study design

Allocation
Randomised controlled trial
Intervention model
Parallel
Primary purpose
Treatment
Masking
Blinded (masking used)

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

(1) Exposure to trauma, (2) Meet criteria for PTSD

Exclusion criteria

Suicidal intent, psychotic, substance dependent

Outcome results

None listed

Source: ANZCTR · Data processed: Mar 10, 2026